Procter & Gamble Co

• Procter and Gamble shares rose following strong first-quarter financial results and price target upgrades. • Organic volume expansion and strategic acquisitions supported robust revenue and earnings performance. • Rising input costs caused volatility, while institutional demand and technical indicators signaled bullish momentum.

• First-quarter net sales rose four percent year-over-year to $23.28 billion. • Adjusted core earnings per share reached $2.00, beating analyst estimates. • Management affirmed its full-year fiscal 2027 outlook for organic sales growth.

• Procter & Gamble beat Q3 2026 expectations, maintaining guidance. • Dividend increased for the 70th consecutive year. • Analysts maintain buy ratings, showing positive sentiment.

• Procter & Gamble investing $205 million in Georgia logistics facility. • Analysts expect sustained 2026 growth via brands and pricing strategy. • Company reported strong Q3 FY26 earnings, revenue, and organic sales.

• Estée Lauder merger talks with Puig officially terminated. • Company raised fiscal 2026 outlook, signaling standalone confidence. • Analysts upgraded rating; price target average $95.23.

• Procter & Gamble stock rose 4.72% on strong Q3 FY26 earnings. • Q3 net sales reached $21.2 billion, exceeding estimates. • Company increased quarterly dividend and reiterated FY26 guidance.